Korean Aerospace Industries (KAI) has awarded a contract to UK-based manufacturing company Cobham for the design and delivery of a pilot oxygen system for the future KF-X multi-role fighter aircraft.
Under the terms of the deal, Cobham Mission Systems will be responsible for delivering the next-generation system and will leverage its oxygen concentrator technology and electronic seat-mounted regulator.
Go deeper with GlobalData
The latest Cobham system will be integrated on-board the KF-X aircraft, which is currently under development.
The new system will help address or exceed the current requirements and will be capable of undergoing spiral upgrades as and when new technologies such as pilot breathing sensors are rolled out.
Cobham Mission Systems vice-president and general manager Kevin McKeown said: “Cobham has a long history of working with KAI on a number of aircraft platforms.
“We are very excited that KAI selected Cobham’s latest oxygen concentrator solution for its newest platform.
“The KF-X programme is strategically important for Cobham and this contract award will allow us to continue to lead the market in life support oxygen systems for military aircraft.”
The current multi-year contract will help support the entire engineering, manufacturing and development (EMD) phase of the KF-X programme.
The present award is the fourth contract received by Cobham from KAI for the programme.
Under the previous contracts, Cobham is providing KAI with missile ejection launchers (MEL), a full range of communication, navigation and identification (CNI) conformal antennas, as well as external fuel tanks and pylons for KF-X.
